Increasing evidence has indicated that IGF2BP3 is highly expressed and promotes tumor progression in NSCLC, [44] however, the molecular mechanism of IGF2BP3 in NSCLC has not been elucidated. This evidence concerns the gene IGF2BP3 and neoplasm.